Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$1.32 - $3.79 $207,719 - $596,405
-157,363 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$1.06 - $1.51 $362,801 - $516,821
-342,266 Reduced 68.5%
157,363 $195,000
Q3 2020

Nov 16, 2020

BUY
$1.15 - $2.1 $222,275 - $405,894
193,283 Added 63.09%
499,629 $679,000
Q2 2020

Aug 14, 2020

BUY
$0.48 - $1.67 $147,046 - $511,597
306,346 New
306,346 $389,000
Q1 2019

May 15, 2019

SELL
$2.56 - $4.48 $138,147 - $241,758
-53,964 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$2.98 - $6.86 $52,638 - $121,175
17,664 Added 48.66%
53,964 $162,000
Q3 2018

Nov 14, 2018

BUY
$5.36 - $7.83 $194,568 - $284,229
36,300 New
36,300 $270,000
Q4 2017

Feb 14, 2018

SELL
$3.73 - $4.6 $52,593 - $64,859
-14,100 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$3.9 - $6.78 $54,990 - $95,598
14,100
14,100 $59,000

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $3.88M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.